Clinical Trial Information Request for Protocol 26-015 Title A phase II study of ivonescimab as monotherapy or in combination with platinum/pemetrexed chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) harboring actionable genomic alterations (AGAs) PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone